688389 Stock Overview
Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 688389 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Shenzhen Lifotronic Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.17 |
| 52 Week High | CN¥22.87 |
| 52 Week Low | CN¥12.27 |
| Beta | 0.46 |
| 1 Month Change | -8.89% |
| 3 Month Change | 21.75% |
| 1 Year Change | -33.26% |
| 3 Year Change | -30.41% |
| 5 Year Change | -10.18% |
| Change since IPO | -22.72% |
Recent News & Updates
Is Shenzhen Lifotronic Technology (SHSE:688389) A Risky Investment?
Oct 24
Investors Still Aren't Entirely Convinced By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Earnings Despite 33% Price Jump
Oct 02Recent updates
Is Shenzhen Lifotronic Technology (SHSE:688389) A Risky Investment?
Oct 24Investors Still Aren't Entirely Convinced By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Earnings Despite 33% Price Jump
Oct 02Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital
Aug 16Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?
Jul 25Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E
May 24Shenzhen Lifotronic Technology (SHSE:688389) Might Have The Makings Of A Multi-Bagger
Apr 17Shareholder Returns
| 688389 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -7.4% | -3.5% | -2.7% |
| 1Y | -33.3% | -9.6% | 11.8% |
Return vs Industry: 688389 underperformed the CN Medical Equipment industry which returned -9.6% over the past year.
Return vs Market: 688389 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 688389 volatility | |
|---|---|
| 688389 Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688389 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688389's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1,680 | Ming Long Hu | www.lifotronic.com |
Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products.
Shenzhen Lifotronic Technology Co., Ltd. Fundamentals Summary
| 688389 fundamental statistics | |
|---|---|
| Market cap | CN¥6.50b |
| Earnings (TTM) | CN¥381.08m |
| Revenue (TTM) | CN¥1.19b |
17.1x
P/E Ratio5.4x
P/S RatioIs 688389 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688389 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.19b |
| Cost of Revenue | CN¥399.06m |
| Gross Profit | CN¥794.32m |
| Other Expenses | CN¥413.23m |
| Earnings | CN¥381.08m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.89 |
| Gross Margin | 66.56% |
| Net Profit Margin | 31.93% |
| Debt/Equity Ratio | 32.2% |
How did 688389 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield32%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 10:11 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shenzhen Lifotronic Technology Co., Ltd. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhu Chen | Citic Securities Co., Ltd. |
| Shuo Song | Citic Securities Co., Ltd. |
| Jiabo Zhang | Guosen Securities Co., Ltd. |